Liz Stokes
Colleges
Publications in Press
Liz Stokes
BSc MSc DPhil
Senior Researcher
Liz joined the Health Economics Research Centre in November 2009, having worked at Keele University (2001-2007) and Liverpool John Moores University (2008-2009) and in this time completed an MSc in Medical Statistics at the University of Leicester.
Liz’s research interests lie in economic evaluation and particularly in costing within economic evaluations. She has worked on many cost-effectiveness analyses alongside randomised controlled trials in areas such as blood transfusion, and cardiac and thoracic surgery, and has used decision modelling to assess the cost-effectiveness of additional tests to guide treatment decisions for several cardiac populations. Liz completed a doctoral thesis at the University of Oxford in 2016 on the costs and cost-effectiveness of transfusion management strategies in cardiac surgery. Liz is a Research Advisor for the Research Design Service - South Central.
Recent publications
-
Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study).
Baos S. et al, (2020), BMJ Open, 10
-
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.
Lim E. et al, (2020), BMJ Open, 10, e038892 - e038892
-
Conventional versus minimally invasive extracorporeal circulation in patients undergoing cardiac surgery: protocol for a randomised controlled trial (COMICS).
COMICS investigators None., (2020), Perfusion
-
Study Protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multi-centre randomised controlled trial with an internal pilot (The VIOLET study)
STOKES E. and WORDSWORTH S., (2019), BMJ Open
-
A national registry to assess the value of cardiovascular magnetic resonance imaging after primary percutaneous coronary intervention pathway activation: a feasibility cohort study
(2019), Health Services and Delivery Research